MARKET

SPPI

SPPI

Spectrum Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

10.29
+0.45
+4.57%
After Hours: 10.29 0 0.00% 18:55 12/09 EST
OPEN
9.80
PREV CLOSE
9.84
HIGH
10.38
LOW
9.72
VOLUME
2.58M
TURNOVER
--
52 WEEK HIGH
13.20
52 WEEK LOW
6.22
MARKET CAP
1.16B
P/E (TTM)
-7.7386
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SPPI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

SPPI News

  • Kinase inhibitors in focus after Merck bid for ArQule
  • Seeking Alpha - Article.15h ago
  • Why Is Spectrum Pharma (SPPI) Up 23.9% Since Last Earnings Report?
  • Zacks.2d ago
  • Will Spectrum Pharmaceuticals Continue to Surge Higher?
  • Zacks.4d ago
  • Options Traders Expect Huge Moves in Spectrum Pharmaceuticals (SPPI) Stock
  • Zacks.11/27 13:44

More

Industry

Biotechnology & Medical Research
+0.53%
Pharmaceuticals & Medical Research
+0.23%

Hot Stocks

Name
Price
%Change

About SPPI

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company operates through developing and commercializing oncology and hematology drug products segment. It focuses on developing ROLONTIS and POZIOTINIB. ROLONTIS is being investigated for the treatment of chemotherapy-induced neutropenia. POZIOTINIB is an oral pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR, HER) Family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations.
More

Webull offers Spectrum Pharmaceuticals, Inc. (SPPI) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.